Skip to content

Validation Study for Endometriosis PRO

Validation Study to Assess Psychometric Properties of a Newly Developed Patient Reported Outcome Tool for Endometriosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01643122
Acronym
VALEPRO
Enrollment
275
Registered
2012-07-17
Start date
2012-08-31
Completion date
2013-09-30
Last updated
2014-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

Endometriosis, Validation study

Brief summary

Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confirmed by laparoscopy.

Interventions

OTHERNo drug

Patients with expected stable endometriosis management status (EMS), i.e. patients who have not planned a change in endometriosis treatment or a therapeutic surgical procedure in the next 12 weeks and have had no change in endometriosis treatment or therapeutic surgical procedure in the previous 4 weeks.lease specify as free-text; for drugs include daily dose, dosage form dosage frequency and duration (if appl. and possible for the OS/NIS).

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women with endometriosis confirmed by laparoscopy or laparotomy within five years before the baseline visit * Good general health (except for findings related to endometriosis) as proven by medical history * Patient has experienced endometriosis symptoms (i.e. pain) in the past 4 weeks, as assessed by a numerical rating scale (NRS)

Exclusion criteria

* Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results * Undiagnosed abnormal genital bleeding * Abuse of alcohol, drugs, or medicine (e.g., laxatives) * Simultaneous participation in another clinical trial. Participation in another clinical trial prior to study entry that might have an impact on the study objectives, at the discretion of the investigator. * Major surgery scheduled for the study period, except therapeutic surgical procedure for endometriosis * Close affiliation with the study site; e.g. a close relative of the investigator, dependent person (e.g. employee or student of study site) * Inability to cooperate with the study procedures for any reason, including the following examples: language comprehension, psychiatric illness, inability to get to the study site * Previous enrollment to this study * Regular use of pain medication due to other underlying diseases * Known pregnancy

Design outcomes

Primary

MeasureTime frame
Endometriosis symptoms rated by the Endometriosis Symptom DiaryUp to 24 weeks

Countries

Germany, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026